Determination of tetanus antibodies by a double-antigen enzyme-linked immunosorbent assay in individuals of various age groups

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 24, Issue 8, 2005, Pages 523-528

  Caglar, K ^a   Karakus, R ^a   Aybay, C ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

TETANUS ANTIBODY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANALYTIC METHOD; ANTIBODY DETECTION; ARTICLE; CHILD; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNE RESPONSE; INFANT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TURKEY (REPUBLIC); VACCINATION;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIBODIES, BACTERIAL; CLOSTRIDIUM TETANI; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LOGISTIC MODELS; MIDDLE AGED; TETANUS; TURKEY; URBAN POPULATION;

EID: 26244433925     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-005-1372-0     Document Type: Article

References (41)

1. Oladiran I, Meier DE, Ojelade AA, OlaOlarun DA, Adeniran A, Tarpley JL (2002) Tetanus: continuing problem in the developing world. World J Surg 26:1282-1285
2. Vandelaer J, Birmingham M, Gasse F, Kurian M, Shaw C, Gamier S (2003) Tetanus in developing countries: an update on the Maternal and Neonatal Tetanus Elimination Initiative. Vaccine 21:3442-3445
3. Ergonul O, Erbay A, Eren S, Dokuzoguz B (2003) Analysis of the case fatality rate of tetanus among adults in a tertiary hospital in Turkey. Eur J Clin Microbiol Infect Dis 22:188-190
4. Galazka AM (1993) The immunological basis for immunization series. Module 3: tetanus. Document no. WHO/EPI/GEN/93.13. World Health Organization, Geneva
5. Deming MS, Roungou JB, Kristiansen M, Heron I, Yango A, Guenengafo A, Ndamobissi R (2002) Tetanus toxoid coverage as an indicator of serological protection against neonatal tetanus. Bull World Health Organ 80:696-703
6. de la Chapelle A, Lavabre O, Pinsard M, Delamonica J, Relyveld EH (2002) Tetanus in a renal transplant recipient exhibiting the presence of circulating antitetanus antibodies determined by ELISA. Biomed Pharmacother 56:208-210
7. Crone NE, Reder AT (1992) Severe tetanus in immunized patients with high antitetanus titres. Neurology 42:761-764
8. Gergen PJ, McQuillan GM, Kiely M, Ezzati-Rice TM, Sutter RW, Virella G (1995) A population-based serologic survey of immunity to tetanus in the United States. N Engl J Med 332:761-766
9. Heath TC, Smith W, Capon AG, Hanlon M, Mitchell P (1996) Tetanus immunity in an older Australian population. Med J Aust 164:593-596
10. Kruszon-Moran DM, McQuillan GM, Chu SY (2004) Tetanus and diphtheria immunity among females in the United States: are recommendations being followed? Am J Obstet Gynecol 190:1070-1076
11. McQuillan GM, Kruszon-Moran DM, Deforest A, Chu SY, Wharton M (2002) Serologic immunity to diphtheria and tetanus in the United States. Ann Intern Med 136:660-666
12. Brabin L, Fazio-Tirrozzo G, Shahid S, Agbaje O, Maxwell S, Broadhead R, Briggs N, Brabin B (2000) Tetanus antibody levels among adolescent girls in developing countries. Trans R Soc Trop Med Hyg 94:455-459
13. Vogel M, Lai L, Rudolf MP, Curcio-Vonlanthen V, Miescher S, Stadler BM (1996) Cross-reactive antitetanus and antimelittin Fab fragments by phage display after tetanus toxoid immunization. Hum Antibodies Hybridomas 7:11-20
14. Elm J, Desowitz R, Diwan A (1998) Serological cross-reactivities between the retroviruses HIV and HTLV-1 and the malaria parasite Plasmodium falciparum. P N G Med J 41:15-22
15. Magnarelli LA, Anderson JF, Johnson RC (1987) Cross-reactivity in serological tests for Lyme disease and other spirochetal infections. J Infect Dis 156:183-188
16. Sood SK, Rubin LG, Blader ME, Ilowite NT (1993) Positive serology for Lyme borreliosis in patients with juvenile rheumatoid arthritis in a Lyme borreliosis endemic area: analysis by immunoblot. J Rheumatol 20:739-741
17. Keymeulen B, Somers G, Naessens A, Verbruggen LA (1993) False-positive ELISA serologic test for Lyme borreliosis in patients with connective tissue diseases. Clin Rheumatol 12:526-528
18. Weiss NL, Sadock VA, Sigal LH, Phillips M, Merryman PF, Abramson SB (1995) False-positive seroreactivity to Borrelia burgdorferi in systemic lupus erythematosus: the value of immunoblot analysis. Lupus 4:131-137
19. Wilson M, Remington JS, Clavet C, Varney G, Press C, Ware D (1997) Evaluation of six commercial kits for detection of human immunoglobulin M antibodies to Toxoplasma goudii. J Clin Microbiol 35:3112-3115
20. Palosuo T, Aho K (1983) Technical falsely positive rheumatoid factor by ELISA in sera with elevated IgM levels. Med Biol 61:203-207
21. Martins TB, Jaskowski TD, Mouritsen CL, Hill HR (1995) An evaluation of the effectiveness of three immunoglobulin G (IgG) removal procedures for routine IgM serological testing. Clin Diagn Lab Immunol 2:98-103
22. Bouillon M, Aubin E, Roberge C, Bazin R, Lemieux R (2002) Reduced frequency of blood donors with false-positive HIV-1 and -2 antibody EIA reactivity after elution of low-affinity nonspecific natural antibodies. Transfusion 42:1046-1052
23. Simonsen O, Bentzon MW, Heron I (1986) ELISA for the routine determination of antitoxic immunity to tetanus. J Biol Stand 14:231-239
24. Hendriksen CF, van der Gun JW, Nagel J, Kreeftenberg JG (1988) The toxin binding inhibition test as a reliable in vitro alternative to the toxin neutralization test in mice for the estimation of tetanus antitoxin in human sera. J Biol Stand 16:287-297
25. Kristiansen M, Aggerbeck H, Heron I (1997) Improved ELISA determination of antidiphtheria and/or antitetanus antitoxin antibodies in sera. APMIS 105:843-853
26. Bieber F (1992) Biotinylating monoclonal antibodies. In: Peters JH, Baumgarten H (eds) Monoclonal antibodies. Springer-Verlag, Heidelberg, pp 299-303
27. Danilova E, Shiryayev A, Skogen V, Kristoffersen EK, Sjursen H (2005) Short-term booster effect of diphtheria toxoid in initially long-term protected individuals. Vaccine 23:1446-1450
28. Bonetti TC, Succi RC, Weckx LY, Tavares-Lopes L, de Moraes-Pinto MI (2004) Tetanus and diphtheria antibodies and response to a booster dose in Brazilian HIV-1-infected women. Vaccine 22:3707-3712
29. Olander RM, Wuorimaa T, Kayhty H, Leroy O, Dagan R, Eskola J (2001) Booster response to the tetanus and diphtheria toxoid carriers of 11-valent pneumococcal conjugate vaccine in adults and toddlers. Vaccine 20:336-341
30. Ergonul O, Sozen T, Tekeli E (2001) Immunity to tetanus among adults in Turkey. Scand J Infect Dis 33:728-730
31. Kurtoglu D, Gozalan A, Coplu N, Miyamura K, Morita M, Esen B, Akin L (2004) Community-based seroepidemiology in three selected provinces in Turkey. Jpn J Infect Dis 57:10-16
32. Maple PAC, Jones CS, Wall EC, Vyse A, Edmunds WJ, Andrews NJ, Miller E (2001) Immunity to diphtheria and tetanus in England and Wales. Vaccine 19:167-173
33. Reid PM, Brown D, Coni N, Sama A, Waters M (1996) Tetanus immunization in the elderly population. J Accid Emerg Med 13:184-185
34. Symeonidis N, Symeonidis C, Soulioi E, Houiazi E, Diza E, Symeonidis A, Antoniadis A (2003) Serological survey of immunity to tetanus in adult population of Northern Halkidiki, Greece. Eur J Epidemiol 18:1147-1152
35. Aue A, Hennig H, Krüger S, Closius B, Kirchner H, Seyfarth M (2003) Immunity against diphtheria and tetanus in German blood donors. Med Microbiol Immunol 192:93-97
36. Stark K, Schonfeld C, Barg J, Molz B, Vomwald A, Bienzle U (1999) Seroprevalence and determinants of diphtheria, tetanus, and poliomyelitis antibodies among adults in Berlin, Germany. Vaccine 17:844-850
37. Ozturk A, Gokahmetoglu A, Erdem F, Misguroglu AS (2003) Tetanus antitoxin levels among adults over 40 years of age in Central Anatolia, Turkey. Clin Microbiol Infect 9:33-38
38. Soyletir G, Yagci A, Topkaya A, Ciragil P (1999) Detection of antitetanus antibodies in Turkish population. Trop Doct 29:161-163
39. Redwan el-RM, Al-Awady MK (2002) Prevalence of tetanus immunity in Egyptian population. Hum Antibodies 11:55-59
40. Pepersack T, Tumeer M, De Breucker S, Stubbe M, Beyer I (2005) Tetanus immunization among geriatric hospitalized patients. Eur J Clin Microbiol Infect Dis 24:495-496
41. de Melker HE, van den Hof S, Berbers GAM, Nagelkerke NJD, Rümke HJ, Conyn-van Spaendonck MAE (2000) A population-based study on tetanus antitoxin levels in Netherlands. Vaccine 18:100-108